Introduction In the domain of oncology, immunotherapy has emerged as a pioneering methodology, harnessing the body's immune system to combat malignant tumors. There are many immunotherapeutic approaches, but Chimeric Antigen Rece..
Introduction Cytokine Release Syndrome (CRS) is an immune system overreaction triggered by therapies like immunotherapy or CAR-T cell treatment. It prompts an influx of cytokines, causing symptoms ranging from fever to potentiall..
Patients undergoing outpatient CAR T-cell therapy for cancer must be cared for by a multidisciplinary team that includes nurse coordinators, according to a poster presented at the 49th Annual Oncology Nursing Society Conference. ..
Introduction CAR T cell therapy, an innovative form of immunotherapy, has demonstrated exceptional efficacy in the treatment of specific tumors by leveraging the potency of a patient's own immune system. Recently, scientists have..
Feb 2024: China's pioneering efforts in creating breakthrough cancer therapeutics have gained traction with the introduction of chimeric antigen receptor (CAR)-engineered T-cell (CAR T) therapy for multiple myeloma, a devastatin..
Discover the magic of CAR-T treatment! Read our blog on patient selection for CAR T therapy. Are you the ideal candidate for this innovative cancer treatment? Find out and begin your personalized journey to cancer recovery. He..
Tá an réabhlóideach CAR T Cell Therapy ag athrú an scéil maidir le conas a dhéileálaimid le hailse, rud a fhágann go bhfuil sé níos pearsanta agus níos cumhachtaí. Úsáideann an teiripe is déanaí seo cealla imdhíonachta an othair féin agus modhnaítear iad go géiniteach chun díriú orthu agus chun cinn.
Bealtaine 2023: Is forbairt nuálaíoch í teiripe T-chealla gabhdóra antaigin chimeric (CAR) i réimse na teiripe ailse indibhidiúla. Déantar cealla T an othair féin a mhodhnú go géiniteach le linn an phróisis déantúsaíochta chun a..
Márta 2023: Bheadh an chéad chaibidil de chuimhní cinn Sam Neill ina turraing ollmhór do dhuine nach raibh aon eolas aige air roimhe seo. Tosaíonn sé amach greannmhar go leor: snáth iontach faoina iníon Elena á cheistiú faoi thaitneamhachtaí a hathar.
Márta 2023: Achoimre Achomair: Is é cuspóir na trialach cliniciúla seo a fháil amach an féidir teiripe T-chealla CAR receptor antigen anti-MESO a úsáid chun ailse ubhagán epithelial a chóireáil a tháinig ar ais nó a stop freagra a thabhairt ar dhaoine eile.